India will appeal before CAS against WADA decision to suspend NDTL’s accreditation: Rijiju

Sports Secretary Radhey Shyam Julaniya also expressed surprise at the decision and alleged that a big business interest was the reason behind the world agency’s move.

August 23, 2019 08:03 pm | Updated 08:03 pm IST - New Delhi

File photo of athletes coming out of National Dope Testing Laboratory (in New Delhi.

File photo of athletes coming out of National Dope Testing Laboratory (in New Delhi.

India will file an appeal before the Court of Arbitration for Sport in Switzerland against the decision of the WADA to suspend the accreditation of National Dope Testing Laboratory, Sports Minister Kiren Rijiju said on Friday.

The World Anti-Doping Agency suspended the NDTL’s accreditation for six months in a massive blow to the country’s anti-doping programme, which left the sports ministry surprised as it claimed WADA’s concerns were duly addressed.

Mr. Rijiju said it was disheartening for the WADA to take such a decision after the NDTL had begun a “course correction” of the issues faced by it “in the past“.

“There were some issues in the past. After taking over as sports minister, I have taken cognizance of those issues and a course correction has been initiated. It is disheartening that despite these efforts, WADA has taken this stance,” Mr. Rijiju said in a statement.

“We will appeal against this ban (at the CAS in Lausanne) and the process of appeal is already underway,” he added.

Sports Secretary Radhey Shyam Julaniya also expressed surprise at WADA’s decision to suspend NDTL and alleged that a big business interest was the reason behind the world agency’s move.

The NDTL, which got WADA accreditation in 2008, is no longer authorised to carry out testing of the samples as the suspension is effective August 20.

“We have addressed all the concerns raised by a WADA team during its last visit in September 2018. So, the suspension came as a surprise to us because they are administering medicine when the disease has already been cured,” Mr. Julaniya told PTI.

“There is a huge business interest behind this decision because the cost of testing in our laboratory is much cheaper than anywhere in the world. Many East African countries have approached us to test their samples and it seems it didn’t go down well with WADA,” he added.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.